A review of NeuroAiDTM II (MLC901) development in Alzheimer’s disease treatment: promises of a multimodal pathway

Background: Alzheimer’s disease (AD) is a clinical and economic burden on society. Without new treatment, the impact of AD on society could triple by 2050. Aim: After a brief overview of treatments and challenges of new drug developments for AD, we reviewed the preclinical and clinical development...

Full description

Bibliographic Details
Main Authors: Dib, Michel, Ampil, Encarnita, Kee, Hoo Fan, Krespi, Yakup, Al Mahdawi, Akram, Ogun, Shamsideen Abayomi, Pakdaman, Hossein, Rejdak, Konrad
Format: Article
Published: Scientific Research and Community Ltd 2022

Similar Items